[342 Pages Report] The kaempferol market, which was valued at US$ 3.91 billion in 2022, is expected to grow at a CAGR of 4% during the forecast period, reaching US$ 5.79 billion by 2032. Kaempferol provides excellent benefits like reducing the risk of chronic diseases like cancer, strengthening anti-oxidant defense against free radicals, offering resistance against …
Category Archives: Healthcare Trends
Non-Hyaluronic Acid Dermal Filler Market is predicated to increase at a CAGR of 2.6% from 2022 to 2032 | Exclusive Report by FMI
The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032. As per FMI Analysts, the global non-hyaluronic acid dermal filler market is estimated to be valued at US$ 392.7 Million in 2022 and is projected to increase at a CAGR of 2.6% from 2022 to 2032. Cosmetic plastic surgery is commonly used these days, as it …
Breast Biopsy Devices Market is predicated to reach US$ 3.6 Billion by the end of 2032 | Exclusive Report by FMI
The global demand for breast biopsy devices is expected to grow at a CAGR of about 5.5% from 2022 to 2032, with a market valuation of around US$ 2.1 billion in 2022. According to Future Market Insights, the biopsy needle segment as a product will account for approximately 23.4% of the global market in 2021. Market Outlook: …
Molecular Cytogenetics Market to be valued at US$ 6,469.2 Million from 2022 to 2032 | FMI Study
[Report of 300 Pages] The global molecular cytogenetics market is expected to be worth $2,761.9 million in 2022, with a CAGR of 8.9% to reach $6,469.2 million between 2022 and 2032. The changing methodologies for disease diagnosis, rising awareness about viral diseases, and increased government funding in various regions are all contributing to growth. The …
Endoscopic Vessel Harvesting System Market is likely to be valued at US$ 669.10 Million by 2032 | FMI Study
[Report of 333 Pages] During the forecast period, the endoscopic vessel harvesting system market is expected to grow at a CAGR of 3.7%. The market is expected to be worth US$ 505.63 million in 2022 and US$ 669.10 million by 2032. With the rising prevalence of cardiovascular disease, constant technological innovation and advancement has become …
Cell Therapy Manufacturing Market size is projected to reach a valuation of ~US$ 13.9 Billion by 2032 | FMI
As per Future Market Insights’ latest industry analysis, the valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Bn in 2032. Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. Introduction of …
Disposable Endoscopes Market is likely to reach a valuation of US$ 5.3 billion by 2032 | Exclusive Report by FMI
As per Future Market Insights’ latest analysis, valuation of the global disposable endoscopes market was around US$ 909.9 Million in 2021. The market is projected to exhibit a CAGR of close to 17.6% from 2022 to 2032 and reach an estimated valuation of around US$ 5.3 Billion in 2032. Endoscope-related infections can be differentiated into endogenous and exogenous. Presence of microbes that have the ability …
Laband Syndrome Therapeutics Market Share 2023 to 2033 | By SI Group, Selleckchem, BASF, Merck, Takeda
According to a recent FMI report, the global Laband Syndrome Therapeutics market demand will develop at a compound annual growth rate (CAGR) of 5.2% between 2023 and 2033. According to the report, the market will be worth US$ 5 billion by the end of the evaluation period. There is a growing public awareness of rare …
Alcohol Use Disorder Treatment Market Size 2023 to 2033 | By BioCorRx, Merck, Alkermes, Omeros
According to a recent FMI analysis, the worldwide Alcohol Use Disorder Treatment market demand is expected to grow at a 6.4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 1300 million by the end of the evaluation period. The increasing number of drug awareness campaigns, prevention programmes, and technology …
Dengue Fever Treatment Market Growth 2023 to 2033 | By Perrigo, ABIVAX, Mylan N.V, Pfizer, Sanofi
The global Dengue Fever Treatment Market size is expected to be worth US$ 877.82 million in 2023 and US$ 5435.25 million by 2033, with a CAGR of 20% from 2023 to 2033. Dengue Fever Therapy market expanded at an 11% CAGR between 2018 and 2022. Dengue fever has increased rapidly in recent decades, according to …